FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132106774> ?p ?o ?g. }

• W2132106774 endingPage "63" @default.
• W2132106774 startingPage "55" @default.
• W2132106774 abstract "Evolution of cryotherapy for prostate cancer is likely to result in parenchyma-sparing modifications adjacent to the urethra and neurovascular bundle. Results of initial series of focal therapy to minimize cryosurgery-related morbidity without compromising oncologic control have been encouraging, but limited in short-term outcomes. To retrospectively report (1) median 3.7-yr follow-up experience of primary focal cryotherapy for clinically unilateral prostate cancer with oncologic and functional outcomes, and (2) matched-pair analysis with contemporaneous patients undergoing radical prostatectomy (RP). Over 8.5 yr (September 2002 to March 2011), focal cryoablation (defined as ablation of one lobe) was performed in 73 carefully selected patients with biopsy-proven, clinically unilateral, low-intermediate risk prostate cancer. All patients underwent transrectal ultrasound (TRUS) and Doppler-guided sextant and targeted biopsies at entry. Post-therapy follow-up included measuring prostate-specific antigen (PSA) level every 3–6 mo; TRUS biopsies at 6–12 mo and yearly, as indicated; and validated symptom questionnaires. Matched-pair analysis compared oncologic outcomes of focal cryotherapy and RP (matched for age, PSA, clinical stage, and biopsy Gleason score). Complete follow-up was available in 70 patients (median follow-up: 3.7 yr; range: 1–8.5 yr). No patient died or developed metastases. Precryotherapy mean PSA was 5.9 ng/ml and Gleason score was 6 (n = 30) or 7 (n = 43). Postcryotherapy mean PSA was 1.6 ng/ml (70% reduction compared to precryotherapy; p < 0.001). Of 48 patients undergoing postcryotherapy biopsy, 36 (75%) had negative biopsies; positive biopsy for cancer (n = 12) occurred in the untreated contralateral (n = 11) or treated ipsilateral lobe (n = 1). Complete continence (no pads) and potency sufficient for intercourse were documented in 100% and 86% of patients, respectively. Matched-pair comparison of focal cryotherapy and RP revealed similar oncologic outcome, defined as needing salvage treatment. Primary focal cryoablation for low-intermediate risk unilateral cancer affords encouraging oncologic and functional outcomes over a median 3.7-yr follow-up. Close surveillance with follow-up whole-gland biopsies is mandatory." @default.
• W2132106774 created "2016-06-24" @default.
• W2132106774 creator A5002937255 @default.
• W2132106774 creator A5011277587 @default.
• W2132106774 creator A5024525598 @default.
• W2132106774 creator A5047742848 @default.
• W2132106774 creator A5079456405 @default.
• W2132106774 creator A5084766370 @default.
• W2132106774 creator A5085986038 @default.
• W2132106774 creator A5090012714 @default.
• W2132106774 date "2012-07-01" @default.
• W2132106774 modified "2023-09-25" @default.
• W2132106774 title "Focal Cryotherapy for Clinically Unilateral, Low-Intermediate Risk Prostate Cancer in 73 Men with a Median Follow-Up of 3.7 Years" @default.
• W2132106774 cites W1974182592 @default.
• W2132106774 cites W1974948991 @default.
• W2132106774 cites W1982311990 @default.
• W2132106774 cites W1990119121 @default.
• W2132106774 cites W1991451483 @default.
• W2132106774 cites W1991964551 @default.
• W2132106774 cites W2013971175 @default.
• W2132106774 cites W2061365104 @default.
• W2132106774 cites W2070912263 @default.
• W2132106774 cites W2070994843 @default.
• W2132106774 cites W2098226918 @default.
• W2132106774 cites W2135410692 @default.
• W2132106774 cites W2146699704 @default.
• W2132106774 cites W2147599714 @default.
• W2132106774 cites W2148844122 @default.
• W2132106774 cites W2323116989 @default.
• W2132106774 cites W2792723793 @default.
• W2132106774 doi "https://doi.org/10.1016/j.eururo.2012.03.006" @default.
• W2132106774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22445223" @default.
• W2132106774 hasPublicationYear "2012" @default.
• W2132106774 type Work @default.
• W2132106774 sameAs 2132106774 @default.
• W2132106774 citedByCount "204" @default.
• W2132106774 countsByYear W21321067742012 @default.
• W2132106774 countsByYear W21321067742013 @default.
• W2132106774 countsByYear W21321067742014 @default.
• W2132106774 countsByYear W21321067742015 @default.
• W2132106774 countsByYear W21321067742016 @default.
• W2132106774 countsByYear W21321067742017 @default.
• W2132106774 countsByYear W21321067742018 @default.
• W2132106774 countsByYear W21321067742019 @default.
• W2132106774 countsByYear W21321067742020 @default.
• W2132106774 countsByYear W21321067742021 @default.
• W2132106774 countsByYear W21321067742022 @default.
• W2132106774 countsByYear W21321067742023 @default.
• W2132106774 crossrefType "journal-article" @default.
• W2132106774 hasAuthorship W2132106774A5002937255 @default.
• W2132106774 hasAuthorship W2132106774A5011277587 @default.
• W2132106774 hasAuthorship W2132106774A5024525598 @default.
• W2132106774 hasAuthorship W2132106774A5047742848 @default.
• W2132106774 hasAuthorship W2132106774A5079456405 @default.
• W2132106774 hasAuthorship W2132106774A5084766370 @default.
• W2132106774 hasAuthorship W2132106774A5085986038 @default.
• W2132106774 hasAuthorship W2132106774A5090012714 @default.
• W2132106774 hasConcept C105572291 @default.
• W2132106774 hasConcept C121608353 @default.
• W2132106774 hasConcept C126322002 @default.
• W2132106774 hasConcept C126838900 @default.
• W2132106774 hasConcept C126894567 @default.
• W2132106774 hasConcept C141071460 @default.
• W2132106774 hasConcept C2775934546 @default.
• W2132106774 hasConcept C2776235491 @default.
• W2132106774 hasConcept C2777628079 @default.
• W2132106774 hasConcept C2778902805 @default.
• W2132106774 hasConcept C2779466945 @default.
• W2132106774 hasConcept C2780106285 @default.
• W2132106774 hasConcept C2780149145 @default.
• W2132106774 hasConcept C2780192828 @default.
• W2132106774 hasConcept C2781217009 @default.
• W2132106774 hasConcept C2781406297 @default.
• W2132106774 hasConcept C71924100 @default.
• W2132106774 hasConceptScore W2132106774C105572291 @default.
• W2132106774 hasConceptScore W2132106774C121608353 @default.
• W2132106774 hasConceptScore W2132106774C126322002 @default.
• W2132106774 hasConceptScore W2132106774C126838900 @default.
• W2132106774 hasConceptScore W2132106774C126894567 @default.
• W2132106774 hasConceptScore W2132106774C141071460 @default.
• W2132106774 hasConceptScore W2132106774C2775934546 @default.
• W2132106774 hasConceptScore W2132106774C2776235491 @default.
• W2132106774 hasConceptScore W2132106774C2777628079 @default.
• W2132106774 hasConceptScore W2132106774C2778902805 @default.
• W2132106774 hasConceptScore W2132106774C2779466945 @default.
• W2132106774 hasConceptScore W2132106774C2780106285 @default.
• W2132106774 hasConceptScore W2132106774C2780149145 @default.
• W2132106774 hasConceptScore W2132106774C2780192828 @default.
• W2132106774 hasConceptScore W2132106774C2781217009 @default.
• W2132106774 hasConceptScore W2132106774C2781406297 @default.
• W2132106774 hasConceptScore W2132106774C71924100 @default.
• W2132106774 hasIssue "1" @default.
• W2132106774 hasLocation W21321067741 @default.
• W2132106774 hasLocation W21321067742 @default.
• W2132106774 hasOpenAccess W2132106774 @default.
• W2132106774 hasPrimaryLocation W21321067741 @default.
• W2132106774 hasRelatedWork W1884231116 @default.
• W2132106774 hasRelatedWork W1979374145 @default.

• next